Compare Amphastar Pharmaceuticals Inc (AMPH) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while iShares 1 3 Year Treasury Bond ETF trades at $81.9. The key difference: Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| AMPH | SHY | |
|---|---|---|
Market Cap | $863.95M | — |
Sector | Health | Fixed Income |
52-Week High | $30.81 | $83.18 |
52-Week Low | $16.87 | $81.77 |
Enterprise Value | $1.26B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
SHY, the iShares 1-3 Year Treasury Bond ETF, trades at $81.92, up 0.15% on the day, with a bearish technical bias as moving averages signal selling pressure. Recent news highlights institutional accumulation amid rising Treasury yields and inflation concerns, while dividend distributions remain steady.
The outlook is cautious due to interest rate uncertainty and geopolitical tensions affecting bond markets. Risks include Fed policy shifts and oil price volatility, but SHY offers stability for income-focused investors seeking short-term Treasury exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →
